Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Voyager Therapeutics Ownership Summary

Voyager Therapeutics is owned by 59.64% institutional investors, 17.03% insiders, and 23.33% retail investors. Armistice capital is the largest institutional shareholder, holding 9.33% of VYGR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Voyager Therapeutics	59.64%	17.03%	23.33%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	5.40M	9.33%	$30.60M
Blackrock	5.31M	9.30%	$42.02M
Blackrock funding, inc. /de	5.36M	9.26%	$30.37M
Ecor1 capital	3.92M	6.77%	$22.21M
Vanguard group	3.22M	5.56%	$18.23M
Farallon capital management	2.57M	4.44%	$14.58M
Dimensional fund advisors lp	1.38M	2.39%	$7.83M
Vestal point capital, lp	1.23M	2.13%	$6.97M
Geode capital management	1.08M	1.87%	$6.15M
State street	900.93K	1.56%	$5.11M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Great point partners	826.75K	2.21%	$4.69M
Ecor1 capital	3.92M	0.84%	$22.21M
Armistice capital	5.40M	0.42%	$30.60M
Vestal point capital, lp	1.23M	0.41%	$6.97M
Adar1 capital management	126.79K	0.14%	$718.91K
Globeflex capital l p	291.29K	0.14%	$1.65M
Virtus investment advisers	20.11K	0.09%	$114.00K
Patriot financial group insurance agency	112.20K	0.09%	$636.16K
Clarivest asset management	102.82K	0.08%	$813.32K
Hunter perkins capital management	63.04K	0.07%	$357.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	5.31M	0.00%	915.17K
Vestal point capital, lp	1.23M	0.41%	740.00K
Bank of america corp /de/	648.76K	0.00%	294.32K
Farallon capital management	2.57M	0.07%	278.70K
Dimensional fund advisors lp	1.38M	0.00%	275.57K

Top Sellers

Holder	Shares	% Assets	Change
Federated hermes	-	-	-551.40K
Woodline partners lp	-	-	-300.00K
Renaissance	139.90K	0.00%	-138.77K
Bridgeway capital management	50.11K	0.01%	-135.00K
Great point partners	826.75K	2.21%	-133.20K

New Positions

Holder	Shares	% Assets	Change	Value
Raymond james financial	131.50K	0.00%	131.50K	$745.63K
Gsa capital partners llp	123.46K	0.05%	123.46K	$700.00K
Dynamic technology lab private	47.02K	0.04%	47.02K	$267.00K
Xtx topco	31.38K	0.01%	31.38K	$177.90K
Virtu financial	17.69K	0.01%	17.69K	$100.00K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Capital performance advisors llp	-16.00
Russell investments group	-43.00
Lindbrook capital	-75.00
Covestor	-101.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	131	-0.76%	34,504,533	-1.80%	59	1.62%	67	15.52%	36	-
Sep 30, 2024	132	1.54%	35,137,594	-5.22%	60	1.47%	58	-12.12%	37	-7.50%
Jun 30, 2024	129	-4.44%	37,074,437	7.46%	64	1.01%	66	-26.67%	39	39.29%
Mar 31, 2024	135	22.73%	34,500,823	33.24%	80	2.30%	90	76.47%	28	-12.50%
Dec 31, 2023	110	-3.51%	25,893,556	-1.14%	59	1.63%	51	-8.93%	32	-3.03%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.71M	3.13%	-
Vanguard US Total Market Shares ETF	1.71M	3.10%	-
iShares Russell 2000 ETF	1.19M	2.15%	-10.29K
Vanguard Institutional Extnd Mkt Idx Tr	667.46K	1.22%	-
Vanguard Explorer Inv	457.06K	0.84%	-
Fidelity Small Cap Index	460.83K	0.83%	-8.63K
iShares Russell 2000 Value ETF	435.30K	0.79%	-
BlackRock Health Sciences Opps Inv A	425.92K	0.78%	-
T. Rowe Price Health Sciences	379.61K	0.69%	-158.60K
BlackRock Health Sciences Term Trust	363.32K	0.67%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 02, 2025	Ferguson Toby	Chief Medical Officer	Sell	$34.59K
Apr 02, 2025	Sandrock Alfred	President and CEO	Sell	$37.34K
Feb 20, 2025	Carter Todd Alfred	Chief Scientific Officer	Sell	$14.08K
Feb 20, 2025	Sandrock Alfred	President and CEO	Sell	$49.62K
Feb 20, 2025	Swartz Robin	COO & CBO	Sell	$16.55K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	6
2024 Q4	-	2
2024 Q3	-	-
2024 Q2	-	2
2024 Q1	-	7

VYGR Ownership FAQ

Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 59.64%, followed by 17.03% insiders and 23.33% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 68.48%, which Voyager Therapeutics falls below.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Armistice capital (5.4M shares, 9.33%), Blackrock (5.31M shares, 9.30%), and Blackrock funding, inc. /de (5.36M shares, 9.26%). Together, they hold 27.89% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.21% of its assets in 826.75K Voyager Therapeutics shares, valued at 4.69M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Voyager Therapeutics shares, with 3.13% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools